HOFBF Stock - Hofseth BioCare ASA
Unlock GoAI Insights for HOFBF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $257.42M | $194.87M | $120.45M | $87.62M | $69.25M |
| Gross Profit | $87.86M | $44.19M | $28.51M | $23.10M | $29.72M |
| Gross Margin | 34.1% | 22.7% | 23.7% | 26.4% | 42.9% |
| Operating Income | $-113,204,000 | $-102,529,000 | $-128,618,000 | $-118,565,000 | $-92,021,000 |
| Net Income | $-123,405,000 | $-106,683,000 | $-137,389,000 | $-126,463,000 | $-102,090,000 |
| Net Margin | -47.9% | -54.7% | -114.1% | -144.3% | -147.4% |
| EPS | $-0.30 | $-0.27 | $-0.37 | $-0.35 | $-0.31 |
Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.
Visit WebsiteEarnings History & Surprises
HOFBFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 9, 2025 | — | $-0.01 | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.01 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 10, 2024 | — | $-0.01 | — | — |
Q1 2024 | Jan 4, 2024 | — | $-0.01 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.01 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.01 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about HOFBF
What is HOFBF's current stock price?
What is the analyst price target for HOFBF?
What sector is Hofseth BioCare ASA in?
What is HOFBF's market cap?
Does HOFBF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to HOFBF for comparison